Beruflich Dokumente
Kultur Dokumente
Oncoplastic surgery refers to several surgical techniques by which segments of malignant breast tissue are removed to achieve wide surgical margins while the remaining glandular tissue is transposed to achieve the best possible cosmetic outcome. We summarise the general approach to oncoplastic lumpectomy for surgeons who recognise the limitations of standard lumpectomy for large breast cancers, and review different cancer distributions in the breast and their associated imaging characteristics. Full-thickness broglandular excision of the mass and surrounding breast tissue allows resection with wide surgical margins. Subsequent breast-ap advancement (mastopexy) results in closure of the resulting surgical defect with good or excellent cosmetic closure. These approaches can improve both the aesthetic outcome of breast cancer resections and the likelihood of surgeons obtaining wide surgical margins in preparation for breast-conserving radiotherapy. Advanced volume-displacement techniques, which are based on the key principles of breast reductive surgery, can greatly increase the options for breast conservation in complex cancer cases. Breast-conservation therapy with lumpectomy is a valuable component of breast cancer treatment, with an equivalent survival outcome to that of mastectomy.1,2 In addition to physical preservation, women who undergo breast conservation have a better view of their body image, are more comfortable with nudity and breast caressing, and might have less adverse physical sequelae from asymmetry, chest wall adhesions, and numbness associated with mastectomy.3,4 However, for breast conservation to be effective, surgeons need to remove cancers completely with an adequate surgical margin width and maintain the breasts shape and appearance.5 The undertaking of both goals together in the same operation can be challenging, depending on the tumour location and relative size in the breast (gure 1). If a lesion is large or located in a region that is too difcult to excise without the risk of cosmetic deformity, special approaches to resection should be considered. The value of full-thickness excision with breast-ap mastopexy closure is intuitively apparent. The term oncoplastic surgery is used differently depending on the specialty in which it is being referred.610 In plastic surgery, the term typically refers to large partial mastectomy combined with a volumereplacement technique of partial breast-myocutaneousap reconstruction using the latissimus dorsi or transrectus abdominus muscles. Oncoplastic surgery has now been used to describe several volumedisplacement operations that are technically simple, in which the defect created by large partial breast excisions is covered by a breast-ap mastopexy closure. In this procedure, breast tissue is advanced along the chest wall to ll the defect created by primary resection (gure 2). Without breast-ap advancement, the loss of breast tissue can create a substantial defect in the shape and appearance of the breast, yielding poor cosmetic results. In breast-ap advancement, a full-thickness segment of breast broglandular tissue is advanced on
http://oncology.thelancet.com Vol 6 March 2005
the chest wall or beneath the skin envelope to best preserve breast shape and appearance. Major reconstructive procedures using myocutaneous aps are technically demanding, time consuming, and need special training to learn and apply properly. The complexity of these total or partial
Figure 1: Three-dimensional orientation of typical breast tumour Tumour is shown relative to skin, chest wall, and nipple-areolar complex.
145
University of Washington
Review
Localised cancers extend from one focus in the breast and seem to expand circumferentially during growth. Segmentally extended cancers are distributed along the length of duct-lobular segments, which themselves form a cone or wedgeshaped distribution in the breast. Irregularly extended cancers have thick branches of stromally invasive carcinoma extending out from the index tumour, crossing through breast tissue irrespective of the segmental anatomy.
breast reconstructive operations demands a two-team operative approach, in which a plastic-surgery team works independently from oncological surgeons to reconstruct the breast after the cancer has been removed. By contrast, many small to intermediately sized cancers can be dealt with by use of simple oncoplastic procedures based on breast-ap advancement. These basic operations are easily taught and are used by surgeons with experience in routine breast surgery, because the techniques are technically straightforward and intuitively obvious after the basic principles are understood. Avoidance of poor cosmetic appearance after wide excision by simple oncoplastic methods will increase the number of women who can be treated with breast-conserving surgery by allowing larger breast excisions with improved cosmetic results that potentially achieve widened surgical margins around the cancer.11 We focus on the use of breastap oncoplastic techniques that do not need myocutaneous-ap reconstruction to achieve the best cosmetic outcomes.
University of Washington
Figure 2: Closure of breast-ap mastopexy advancement in oncoplastic partial mastectomy resection (A) Resection at full thickness from pectoralis fascia to skin, with an overlying skin island to allow proportional reduction in skin and broglandular tissue. (B) Fibroglandular tissue lifted off the pectoralis muscle to allow its advancement over the chest wall. (C) Closure of defect.
146
Review
In classic studies using serial, subgross, whole-organ sectioning of mastectomy specimens, Holland and colleagues16 showed that ductal carcinoma in situ (DCIS) generally occupied one breast segment and was usually distributed in a radial fashion. Amano and coworkers15 recorded that segmentally extended cancers tend to include lesions that are histologically pure or predominant tumours of DCIS. Although some cancers seem to have a multifocal distribution in the breast (ie, include separate islands of disease interspersed with histologically non-affected tissue), Holland and Faverly17 showed that these multifocal lesions were usually contiguous disease arising within one anatomical segment in the breast. Treatment of segmentally extended cancers by standard lumpectomy will probably result in positive margins on excision, or conversely will need a large lumpectomy that is cosmetically unacceptable. Thus, these tumours are best excised by oncoplastic resections with breast-ap advancement. However, if segmental cancers extend to the nipple, which can happen in some extensive DCIS cases, the patient will need resection of the nipple by mastectomy or central lumpectomy.18 Such cancers could present with bloodstained nipple discharge or Pagets disease of the nipple. Irregularly extended cancers tend to be histologically aggressive variants with local growth patterns that are less amenable to breast-conservation treatment if their size becomes prohibitively widespread. In addition to the great need for mastectomy for denitive local control, these lesions could be systemically aggressive with worsened overall prognosis.
Mammography and ultrasound are not as reliable in determining the distribution of non-invasive cancer. DCIS can be seen on both mammography imaging when microcalcications are present and on radiographs. However, the extent of calcications seen mammographically can be a serious underestimation of the degree of histological spread when these calcications in the lesion form centrally but are absent peripherally.19 Because DCIS usually fails to induce mass-like changes, ultrasound has little or no use in measuring the extent of disease in preparation for lumpectomy. Thus, although standard imaging can predict the distribution of locally extended cancers, it might not predict the full extent of segmentally extended cancers in many cases, especially if an important non-invasive component is present. Incomplete excisions are more probable if the mammographical abnormality does not correspond to the entire extent of the lesion.20 This detection is especially likely to fail with low-grade DCIS, because microcalcication deposition is often absent.1 In such events, the surgical margins are often noted to be positive at resection, even if radiographical images of specimens indicate that all disease has been removed. Second operations need to be done either with an oncoplastic, segmentally orientated re-excision or with mastectomy. Therefore, the surgeon should consider the possibility of positive margins when undertaking an initial excision. Ideally, the incision should be placed in a location that will not prevent a good cosmetic re-excision result. Re-excision of cavity margins is usually done through the same incision without any need for extension of the cut. A subsequent mastectomy needs an extended or new incision.
Breast MRI
MRI is making headway for measuring the extent of disease within the breast. Unlike mammography, breast MRI is not affected by the density of surrounding broglandular tissue in determining the presence of invasive cancer. Breast MRI can also show the presence of cancer that is mammographically occult. When mammographically occult lesions are seen on MRI, subsequent breast ultrasound directed to the same area often shows the malignant disease. Therefore, these lesions can be localised preoperatively under ultrasound guidance to plan an accurate oncoplastic resection. In other cases, the distinct area of malignant tissue also cannot be detected on ultrasound. In such events, MRI-guided biopsy techniques can be used to place clips in the breast that can be localised by mammography during lumpectomy. Boetes and colleagues21 compared the accuracy of MRI with that of mammography and ultrasonography to assess the extent of 61 breast tumours in 60 women
147
Review
undergoing mastectomy for carcinoma. The index tumour could not be seen in 10% of cases with mammography, in 15% with ultrasound, but in only 2% with MRI. On mammography and ultrasound images, tumour size was underestimated substantially, by 14% and 18%, respectively, whereas MRI imaging showed no great difference in size compared with that seen in a pathological assessment in this series. Mammography detected 31% of the additional invasive lesions, whereas ultrasound showed 38% and MRI showed 100%. MRI could be especially useful in assessing the extent of disease of invasive lobular carcinoma.22 Compared with mammography and ultrasound, contrast-enhanced MRI has the lowest false-negative rate in detecting invasive lobular carcinoma and has the highest accuracy in measuring the size of these tumours. However, a negative MRI does not stop the need for biopsy in the setting of suspicious mammographical ndings. Occasional cancers, and in particular DCIS, might fail to enhance on MRI but nevertheless be seen on mammography because of radiographically detectable microcalcications.23 Although preliminary data regarding MRI is encouraging, an important limitation of MRI is its high rate of false-positive results. About a third of MRI studies will show some area of enhancement that needs further assessment but ultimately proves to be dense but histologically benign breast tissue.24,25 Practically speaking, the use of MRI in the absence of MRI-guided sampling or clip placement is not recommended, because in many cases the questions raised by studies cannot be resolved before lumpectomy. Additionally, MRI does not always accurately predict the extent of non-invasive cancer, especially when low-grade DCIS is present. Currently, the use of MRI off-trial should be restricted to centres with substantial experience in MRI interpretation and when MRI-guided biopsy is available. MRI could prove to have increased use in planning oncoplastic procedures in the future, but currently the technique would not be considered the standard of care. Furthermore, the high cost of MRI is prohibitive in many health-care settings. More clinical studies regarding patient selection for MRI will undoubtedly shape the future application of this procedure.
The crucial issue is actually margin clearance, which is established by the ratio of tumour-to-breast size rather than absolute tumour dimensions. Serial, subgross, whole-organ sectioning suggests that when margin widths exceed 10 mm, the likelihood of residual disease is small.16 In multivariate analysis, if the tumour margin width is greater than 10 mm, tumour size does not seem to be an independent predictor of local recurrence after breast-conserving therapy.29 Unless histologically adequate margins in surgery are achieved, the absolute tumour size is of secondary importance. However, achievement of the dual goals of oncological clearance and good cosmesis is clearly difcult with increasing tumour size.30 Cosmetic failure with lumpectomy directly relates to breast volume loss, creating an upper limit beyond which volumedisplacement operations will be unsuccessful in achieving an adequate cosmetic result.31,32
Review
carefully, since a subsequent therapeutic procedure might be incorporated into the nal oncoplastic design. Preoperative diagnosis of cancers by use of percutaneous image-guided core needle biopsy or vacuum-assisted sampling is best because where the needle is inserted gives no constraints of the surgical approach to therapeutic lumpectomy. Whenever possible, a diagnosis should be made preoperatively by use of a needle with the goal of a single-stage denitive surgical procedure in mind that yields both widely clear margins and good cosmesis.
If the defect is large, such that there is a great deal of redundant skin over the defect, cosmetic and unsatisfactory infolding results, in which the skin adheres to the chest wall and the nipple deviates towards the lumpectomy site.
Full-thickness lumpectomy
Although typical localised cancers of small size might be excised well by standard lumpectomy, segmentally extended cancers need more creative approaches to surgical excision to remove large breast tumours from nipple to periphery. Oncoplastic techniques need careful preoperative surgical planning, whereby the diseased broglandular tissue and surrounding healthy tissue margin is removed together with skin, creating a full-thickness resection down to the chest wall (gure 2).34 The breast gland is lifted off the pectoralis muscle with preservation of the fascia over the muscle. A notable advantage of this posterior dissection and tissue mobilisation is that it allows bimanual palpation of the target lesion to nd where the breast tissue should best be divided. Additionally, broglandular tissue mobilisation helps close the breast after tumour removal (gure 2B). The undermining of broglandular tissue at the pectoralis fascia is sufciently developed for breast-tissue advancement over the muscle, without being too extensive to threaten the blood supply to residual breast tissue. Cosmetically undesirable displacement of the nippleareolar complex can be avoided by widely undermining the nipple-areolar complex at the level of the pectoralis fascia, which allows the tissues to shift to an anatomically natural position.8
C D
Standard lumpectomy
Figure 3: Comparison of standard lumpectomy with parallelogram mastopexy lumpectomy (A) Before incision. (B) After excision of the lesion. (C) After wound closure with seroma. (D) After seroma reabsorption.
University of Washington
149
Review
Care should be taken to keep major vascular perforators between pectoralis and the breast intact where possible. The main blood supply of the breast comes from the lateral thoracic and internal mammary and intercostal vessels.35 Collateral circulation in the breast allows ligation of the small intercostal perforators without the vascular compromise that takes place when the larger vessels from lateral thoracic and internal mammary arteries remain intact. Overall, the collateral blood supply of the breast allows much exibility for operative approaches to oncoplastic resections. Breast reduction procedures have been successfully done without glandular necrosis based on posterior pedicle aps from the upper, inner, lower, and outer quadrants of the breast. Once the broglandular tissues are appropriately mobilised, the breast defect is closed at full thickness. Margins of the residual cavity are shifted together by the advancement of breast tissue over muscle, and the defect is sutured at the deepest and most supercial edges (gure 2C). Thr resulting seroma cavity can be drained or left to reabsorb. The remaining breast gland heals with a much better long-term cosmetic outcome than that seen with standard lumpectomy. A limitation of full-thickness excision with the skin of the upper inner breast quadrant is that it can cause upward displacement of the nipple-areolar complex, which results when too much skin is removed above the nipple. Grisotti36 denes a no mans land as the area in the upper inner quadrant and superior breast that is at the lateral edge of the pectoralis major muscle. A large skin resection in this area followed by dermoglandular-ap advancement including the nipple-areolar complex will shift the nipple in an upward or medial fashion that would look highly unnatural in location. Grisotti36 suggests that the areola should not be moved higher than 16 cm to the sternal notch or closer than 7 cm to midline. In the upper inner quadrant of the breast, excisions are typically best closed with a simple reapproximation of breast tissue and skin without removal of any skin island.
approach to wire localisation can make the difference between complete excisions with negative margins and the need for surgical re-excision. Multiple hooked wires can help dene the radiographic extent of the tumour, especially with large non-palpable calcic lesions.37 By use of bracketing wires, surgeons should attempt to excise the entire lesion within one piece of tissue. Complete excision should not be attempted by use of one guide wire with large lesions, especially when they contain DCIS, because it could result in incomplete removal. The bracketing-wire technique does not guarantee complete removal of the lesion, but makes this outcome more likely.11 Specimen radiography and orientation should be undertaken in wire-directed cases, because they can provide surgeons with accurate and immediate feedback as to the adequacy of excision. If mass lesions are seen by ultrasound, intraoperative ultrasound can be used to direct the parenchymal excision and assess the thoroughness of wide local excision.38 In some settings, intraoperative ultrasound can be used in place of wire localisation, if target lesions show a similar extent of disease on both mammography and ultrasound imaging.39
150
Review
Figure 4: Batwing mastopexy lumpectomy (A) Preoperative view. (B) Full-thickness excision. (C) Advancement of remaining broglandular tissue to close defect. (D) Final result at closure.
Batwing mastopexy
The batwing mastopexy is a surgical approach that is most ideal for cancers located deep within or adjacent to the nipple-areolar complex but not directly connected with the area (gure 4).11 Two closely similar half-circle incisions are made with angled wings to each side of the areola. Full-thickness excision is undertaken and the broglandular tissue is advanced to close the subsequent defect. This procedure will cause some lifting of the nipple, which can lead to asymmetry. However, in pendulous breasts, this effect might be deemed desirable by the patient. A contralateral lift can be undertaken afterwards to achieve symmetry. Viability of the areola is generally not at risk with batwing mastopexy. However, the extent of dissection behind the nipple restricts the degree of central dissection in the procedure. The blood supply of the external nipple arises from underlying broglandular tissue using major lactiferous sinuses rather than the collateral circulation from surrounding areolar skin. Thus, nipple necrosis could take place if dissection extends high up behind the nipple. Surgeons should carefully mark the edge of the specimen closest to the underside of the nipple if tumours are close to the areola. In some cases, the nipple-areolar complex will be found to be histologically associated with cancer. Because the batwing mastopexy relates to an incision that centres around the complex, the approach can be revised to a central lumpectomy in which the complex itself is resected, which preserves the breast mound shape well.18
http://oncology.thelancet.com Vol 6 March 2005
University of Washington
Review
Figure 5: Postoperative results of radial-excision lumpectomy or cosmetic quadrantectomy (A) Anterior-posterior view. (B) Lateral view.
effective for segmentally distributed cancers in the upper or lateral portion of the breast (gure 6). The donut mastopexy procedure is more technically challenging and time consuming than the radial approach, and uses a modied skin-sparing mastectomy in which only a segment of the breast is removed. Because the technique is a complex operation associated with such wide skin-sparing dissections, it should not be undertaken until basic oncoplastic techniques are fully understood and mastered. Initially, a donut of skin is excised around the nippleareolar complex with a Benelli-type round-block incision that is used as one technique in breast reduction surgery (gure 6A).45 The areola should be carefully separated from the underlying tissues to avoid devascularisation of the areolar skin. Removal of this tissue ring is needed to allow both adequate access to the breast tissue and closure of the skin envelope around the remaining broglandular tissue that will reduce tissue volume overall. A generous, segmentally oriented wedge of tissue is removed, including the entire breast tumour with adequate or generous surgical margins. The remaining broglandular tissue is returned to the skin envelope and sutured at deep and supercial margins to close the resulting defect (gure 6B). A purse-string closure around the nipple completes the procedure, leaving only a periareolar closure at the end of the operation (gures 6C and 6D). Because donut mastopexy lumpectomy needs more complex dissection than other techniques, it is generally reserved for more extensive, segmentally distributed cancers. As a result, most patients will undergo mastectomy if surgical margins of the donut mastopexy procedure are regarded as inadequate.
152
However, because the incision of this operation is exclusively periareolar, a skin-sparing total mastectomy with immediate ap reconstruction remains an excellent option for breast conservation.
Review
sometimes apparent only in retrospect when the nal pathology report becomes available. Correct patient selection is essential.
stitches indicate the superior side) leaves much to be desired, because specimens can be greatly altered during radiography before they are given to pathologists. Multicoloured inking kits are now available with six colours (black, blue, yellow, green, orange, and red) and are very useful for labelling of margins (superior, inferior, medial, lateral, supercial, and deep). Some tumours excised with oncoplastic techniques have complex shapes and are not cubic pieces of tissue. Orientation of the tissue with respect to the breast anatomy is best understood by operating surgeons. If these surgeons personally ink the specimen, they will have much improved condence for correct orientation if margin issues arise. After inking the specimen, surgeons need to apply acetic acid or a similar xative available, to avoid the running of ink during transport. Careful margin inking has shown to be associated with improved outcome as measured by residual tumours in the breast.46 With full-thickness excisions, the supercial and deep margins are already taken in the mastectomy plane, and therefore would not be improved by additional surgery. Surgeons can accurately paint these mastectomy-plane margins, which could help avoid additional and unnecessary re-excision before radiation treatment. However, to adopt an intraoperative inking protocol, a collaborative agreement needs to be established between surgeons and pathologists to avoid misunderstanding or miscommunication.
Figure 6: Donut mastopexy lumpectomy (A) Periareolar incision and removal of skin donut. (B) Full-thickness excision of broglandular tissue and cancer. (C) Purse-string skin closure. (D) Final result at closure.
153
Review
Figure 7: Breast reduction lumpectomy (A) Preoperative image of lower pole cancer at 6 oclock position showing tenting of breast skin overlying an invasive cancer. (B) Skin marking indicating location of cancer and design of operative incision. (C) Intraoperative development of incision before broglandular excision. (D) Final result at closure.
Re-excision lumpectomy
If reoperation is needed for positive surgical margins, surgeons must consider both the surgical approach and timing of the operation. In some instances, use of the same incision is feasible. In others, a new incision and lumpectomy need to be done, which has a technical advantage by allowing some time for healing of the previous excision. If re-excision is delayed for 34 weeks, the previous seroma cavity is nearly reabsorbed, which leaves a brous biopsy cavity that can be easily located by intraoperative palpation. When positive margins are restricted in extent, as can best be determined with differential multicoloured inking, the entire biopsy cavity does not need re-excision. Instead, one or two margins of the previous biopsy cavity can be taken.
154
When all the margins are positive, mastectomy will probably be needed to attain satisfactory surgical clearance. With non-invasive cancer, some surgeons will delay re-excision for 34 months, at which point the seroma cavity has fully reabsorbed. These surgeons think that this approach can yield the best cosmetic outcome after resection.11 It is noteworthy that in a study of specimens removed in a delayed fashion, fewer cases were seen to contain residual carcinoma than for those removed immediately, presumably because of brosis.47 These ndings suggest that local acute repair mechanisms might be responsible for the destruction of up to 50% of the residual tumour load and could complement the cytocidal effects of radiotherapy. This effect was apparent within 2 months (1369 days).
http://oncology.thelancet.com Vol 6 March 2005
Review
Panel: Four-step design of oncoplastic operations 1 Planning of skin incisions and parenchymal excisions following templates used for reduction mammoplasty and mastopexy 2 Reshaping of the gland after parenchymal excision 3 Repositioning of nipple-areolar complex to the centre of new breast mound 4 Correction of contralateral breast to improve symmetry
any subsequent operation, including skin-sparing mastectomy with immediate reconstruction, remains a viable option if surgical margins are seen to be positive. A disadvantage is that the operation is more timeconsuming than other approaches, and needs cautious technique to avoid devascularisation of the breast gland at its posterior aspect by inadvertent division of perforating vessels from the pectoralis muscle.
Review
11
Data for this review were identied by searches of PubMed and references from relevant articles by use of the search terms "oncoplastic surgery" and "breast cancer" or "partial mastectomy" and "cosmetic outcome". Abstracts and reports from meetings were included only when they related directly to previously published work. Only papers published between 1988 and 2004 were included.
13 14 15
16
after successful lumpectomy, which itself could increase breast asymmetry when contralateral reduction is undertaken in the same procedure as the lumpectomy. These issues should be discussed extensively with patients in the planning of an oncoplastic procedure so that they understand the risks and benets of immediate versus delayed contralateral breast reduction.
17
18
19
20
Conclusions
Oncoplastic partial mastectomy with full-thickness excision and removal of overlying skin can be done by surgeons without formal training in plastic surgery but with additional help. The approach needs forethought and planning but is technically achievable with relative ease. Surgical results both from cosmetic and oncological views are desirable. Once surgeons begin to adopt these procedures, they will nd modications and approaches that can be adapted to unique situations. Ultimately, the care of women with breast cancer can be improved with increased satisfaction for both patients and surgeons.
Conict of interest We declare no conicts of interest. References 1 Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002; 347: 123341. 2 Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 2002; 347: 122732. 3 Schover LR. Sexuality and body image in younger women with breast cancer. J Natl Cancer Inst Monogr 1994: 17782. 4 Schrenk P. Surgical and plastic reconstructive therapy of breast carcinoma. Wien Med Wochenschr 2000; 150: 6371. 5 Masetti R, Pirulli PG, Magno S, et al. Oncoplastic techniques in the conservative surgical treatment of breast cancer. Breast Cancer 2000; 7: 27680. 6 Benson JR, Querci della Rovere G. Towards a scientic basis for oncoplastic breast surgery. Eur J Surg Oncol 2003; 29: 629. 7 Brown IM, Wilson CR, Doughty JC, et al. The future of breast surgery: a new sub-speciality of oncoplastic breast surgeons? Breast 2004; 13: 82. 8 Clough KB, Lewis JS, Couturaud B, et al. Oncoplastic techniques allow extensive resections for breast-conserving therapy of breast carcinomas. Ann Surg 2003; 237: 2634. 9 Mustonen P, Harma M. Viewpoints on oncoplastic surgery in invasive breast cancer. Scand J Surg 2002; 91: 255, 25862. 10 Skillman JM, Humzah MD. The future of breast surgery: a new subspecialty of oncoplastic breast surgeons? Breast 2003; 12: 16162. 27 21
22 23 24 25
26
28
29
30
31
32
33
34
Silverstein MJ. An argument against routine use of radiotherapy for ductal carcinoma in situ. Oncology (Huntingt) 2003; 17: 151133. Rew DA. Towards a scientic basis for oncoplastic breast surgery. Eur J Surg Oncol 2003; 29: 10506. Baum M. Is it time for a paradigm shift in the training of breast surgeons as a sub-speciality? Breast 2003; 12: 15960. Rainsbury RM. Training and skills for breast surgeons in the new millennium. Aust N Z J Surg 2003; 73: 51116. Amano G, Ohuchi N, Ishibashi T, et al. Correlation of threedimensional magnetic resonance imaging with precise histopathological map concerning carcinoma extension in the breast. Breast Cancer Res Treat 2000; 60: 4355. Holland R, Schuurmans Stekhoven JH, et al. Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet 1990; 335: 51922. Holland R, Faverly DRG. Whole-organ studies. In: Silverstein MJ, ed. Ductal carcinoma in situ of the breast. Baltimore: Williams & Wilkins, 1997: 23340. Pezzi CM, Kukora JS, Audet IM, et al. Breast conservation surgery using nipple-areolar resection for central breast cancers. Arch Surg 2004; 139: 3237. Holland R, Hendriks JH. Microcalcications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol 1994; 11: 18192. Page DL, Dupont WD, Rogers LW, et al. Continued local recurrence of carcinoma 1525 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995; 76: 1197200. Boetes C, Mus RD, Holland R, et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 1995; 197: 74347. Boetes C, Veltman J, van Die L, et al. The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat 2004; 86: 3137. Bluemke DA, Gatsonis CA, Chen MH, et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 2004; 292: 273542. Van Ongeval C. MR imaging of the breastpresent indications. JBR-BTR 2000; 83: 8084. Trecate G, Tess JD, Vergnaghi D, et al. Breast microcalcications studied with 3D contrast-enhanced high-eld magnetic resonance imaging: more accuracy in the diagnosis of breast cancer. Tumori 2002; 88: 22433. Krishnan L, Stanton AL, Collins CA, et al. Form or function? Part 2. Objective cosmetic and functional correlates of quality of life in women treated with breast-conserving surgical procedures and radiotherapy. Cancer 2001; 91: 228287. Stanton AL, Krishnan L, Collins CA. Form or function? Part 1. Subjective cosmetic and functional correlates of quality of life in women treated with breast-conserving surgical procedures and radiotherapy. Cancer 2001; 91: 227381. Asgeirsson KS, McCulley SJ, Pinder SE, Macmillan RD. Size of invasive breast cancer and risk of local recurrence after breastconservation therapy. Eur J Cancer 2003; 39: 246269. Kerlikowske K, Molinaro A, Cha I, et al. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst 2003; 95: 1692702. Schmidt-Ullrich R, Wazer DE, Tercilla O, et al. Tumor margin assessment as a guide to optimal conservation surgery and irradiation in early stage breast carcinoma. Int J Radiat Oncol Biol Phys 1989; 17: 73338. Bulstrode NW, Shrotria S. Prediction of cosmetic outcome following conservative breast surgery using breast volume measurements. Breast 2001; 10: 12426. Cochrane RA, Valasiadou P, Wilson AR, et al. Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised. Br J Surg 2003; 90: 150509. Brunnert KE. The Osnabrueck experience with reconstruction of the partial mastectomy defect. In: Spear SL, ed. Surgery of the breast: principles and art. Philadelphia: Lippincott-Raven, 1998: 197220. Chang DW, Beahm EK. Reconstructive strategies in breast conserving therapy. In: Singletary SE, Robb GL, Hortobagyi GN, eds. Advanced therapy of breast disease. 2nd edn. Hamilton, Ontario: BC Decker, 2004: 39096.
156
Review
35
36
37
38
39
40 41
42
43
Hoffman S. Inferior pedicle technique in breast reduction. In: Spear SL, ed. Surgery of the breast: principles and art. Philadelphia: Lippincott-Raven, 1998: 76172. Grisotti A. Conservation treatment of breast cancer: reconstructive problems. In: Spear SL, ed. Surgery of the breast: principles and art. Philadelphia: Lippincott-Raven, 1998: 13753. Liberman L, Kaplan J, Van Zee KJ, et al. Bracketing wires for preoperative breast needle localization. AJR Am J Roentgenol 2001; 177: 56572. Kaufman CS, Jacobson L, Bachman B, Kaufman LB. Intraoperative ultrasonography guidance is accurate and efcient according to results in 100 breast cancer patients. Am J Surg 2003; 186: 37882. Rahusen FD, Bremers AJ, Fabry HF, et al. Ultrasound-guided lumpectomy of nonpalpable breast cancer versus wire-guided resection: a randomized clinical trial. Ann Surg Oncol 2002; 9: 99498. Shrotria S. Techniques for improving the cosmetic outcome of breast conservation surgery. Eur J Surg Oncol 2001; 27: 10912. Veronesi U, Luini A, Galimberti V, Zurrida S. Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute trials. World J Surg 1994; 18: 7075. Senofsky GM, Gierson ED, Craig PH, et al. Local excision, lumpectomy, and quadrantectomy: surgical considerations. In: Spear SL, ed. Surgery of the breast: principles and art. Philadelphia: Lippincott-Raven, 1998: 12935. Amanti C, Moscaroli A, Lo Russo M, et al. Periareolar
44
45
46
47
48
49
subcutaneous quadrantectomy: a new approach in breast cancer surgery. G Chir 2002; 23: 44549. Amanti C, Regolo L, Moscaroli A, et al. Total periareolar approach in breast-conserving surgery. Tumori 2003; 89 (suppl 4): 16972. Benelli LC. Periareolar Benelli mastopexy and reduction: the Round Block. In: Spear SL, ed. Surgery of the breast: principles and art. Philadelphia: Lippincott-Raven, 1998: 68596. Neuschatz AC, DiPetrillo T, Steinhoff M, et al. The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast. Cancer 2002; 94: 191724. Nasir N, Rainsbury RM. The timing of surgery affects the detection of residual disease after wide local excision of breast carcinoma. Eur J Surg Oncol 2003; 29: 71820. Petit JY, Garusi C, Greuse M, et al. One hundred and eleven cases of breast conservation treatment with simultaneous reconstruction at the European Institute of Oncology (Milan). Tumori 2002; 88: 4147. Newman LA, Kuerer HM, McNeese MD, et al. Reduction mammoplasty improves breast conservation therapy in patients with macromastia. Am J Surg 2001; 181: 21520.
157